MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Polisseni AF et al. | Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study. | 2013 | Maturitas | pmid:23201326 |
Price T | Progesterone receptor membrane component 1: is metabolism integral to its function and what other steroids are involved? | 2013 | Menopause | pmid:23511707 |
Stanczyk FZ and Winer SA | Effect of hormone therapy on breast epithelial cell proliferation. | 2013 | Menopause | pmid:23615638 |
Cheng G et al. | Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women. | 2013 | Menopause | pmid:23615640 |
Vercellini P et al. | Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life. | 2013 | Hum. Reprod. | pmid:23442755 |
Africander D et al. | Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy. | 2013 | Biochem. Biophys. Res. Commun. | pmid:23473756 |
Ralph LJ et al. | Next steps for research on hormonal contraception and HIV. | 2013 | Lancet | pmid:23810224 |
Zhou J et al. | Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. | 2013 | Maturitas | pmid:23856385 |
Juvkam KH and Gudim HB | [Drug induced displacement of menstruation]. | 2013 | Tidsskr. Nor. Laegeforen. | pmid:23344601 |
Fels H et al. | Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives. | 2013 | Contraception | pmid:23352800 |